VELCADE TM (bortezomib) for Injection, or PS-341

DRUG2 trials

Sponsors

Millennium Pharmaceuticals, Inc.

Conditions

Advanced Non-Small Cell Lung CancerColorectal CarcinomaOther Solid Tumors

Phase 1

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

TerminatedNCT00064636

Millennium Pharmaceuticals, Inc.Advanced Non-Small Cell Lung Cancer, Other Solid Tumors

Start: 2002-12-31Target: 46Updated: 2005-06-24

Phase 2

Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

CompletedNCT00051987

Millennium Pharmaceuticals, Inc.Colorectal Carcinoma

Start: 2002-12-31Target: 175Updated: 2008-02-11